A biopharmaceutical company is looking for ways to slim down household pets. Okava Pharmaceuticals, a San Francisco based company, is introducing a new GLP-1 clinical weight loss study for cats #🐈 ❤️ . MEOW-1, as the study is called, will look to use a miniature implant in cats which will deliver the GLP-1 continuously for up to six months. According to Okava, MEOW-1 is the first-ever weight loss trial using this approach on household pets. #Whattup Doggy 🐾 next? #DANK MEMES